The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M03 | Muscle relaxants | |
| 3 | M03B | Muscle relaxants, centrally acting agents | |
| 4 | M03BA | Carbamic acid esters |
| Code | Title | |
|---|---|---|
| M03BA01 | Phenprobamate | |
| M03BA02 | Carisoprodol | |
| M03BA03 | Methocarbamol | |
| M03BA04 | Styramate | |
| M03BA05 | Febarbamate | |
| M03BA51 | Phenprobamate, combinations excl. psycholeptics | |
| M03BA52 | Carisoprodol, combinations excl. psycholeptics | |
| M03BA53 | Methocarbamol, combinations excl. psycholeptics | |
| M03BA71 | Phenprobamate, combinations with psycholeptics | |
| M03BA72 | Carisoprodol, combinations with psycholeptics | |
| M03BA73 | Methocarbamol, combinations with psycholeptics |
| Active Ingredient | Description | |
|---|---|---|
| Carisoprodol |
Carisoprodol is a centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Most common adverse reactions (incidence > 2%) are drowsiness, dizziness, and headache. Carisoprodol might be mixtured with Aspirin and Codeine Phosphate. |
|
| Methocarbamol |
Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres. |
|
| Phenprobamate |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| ROBAXIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
